ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,079.03
0.80%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Artelo Biosciences Inc (ARTL) Share Price

ARTL Artelo Biosciences Inc

1.44
-0.07 (-4.64%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Artelo Biosciences Inc NASDAQ:ARTL NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.07 -4.64 1.44 1.39 1.46 1.52 1.43 1.52 6,269 23:59:46   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -9.29M -2.9129 -0.49 4.59M
 Type  Size  Price  Time  Units 
 9 1 1.42 20:40:07 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ARTL News
13/05/202413:00GLOBEArtelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
10/05/202414:00GLOBEArtelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
23/04/202413:30GLOBEArtelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
22/04/202413:30GLOBEArtelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
25/03/202412:00GLOBEArtelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
12/03/202413:15GLOBEArtelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
23/01/202413:30GLOBEArtelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
11/02/202420:08PBBUndervalued Property Play465
Data Downloads for ARTL

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Artelo Biosciences Inc Articles